At Web Summit Qatar, AI-powered biotech startups describe how automation, data, and gene editing are filling labor gaps in drug discovery and rare disease treatment.
AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional backing from executives at Meta, OpenAI, and Wiz.